Blair William & CO Precision Biosciences Inc Transaction History

Blair William & CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.4 - $11.66 $202,264 - $318,702	-27,333 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$9.18 - $14.15 $918 - $1,415	-100 Reduced 0.36%	27,333 $315,000
Q2 2021 Aug 12, 2021	BUY	$8.07 - $12.52 $19,230 - $29,835	2,383 Added 9.51%	27,433 $343,000
Q1 2021 May 13, 2021	BUY	$8.57 - $15.79 $28,281 - $52,107	3,300 Added 15.17%	25,050 $259,000
Q4 2020 Feb 09, 2021	BUY	$5.98 - $12.47 $130,065 - $271,222	21,750 New	21,750 $181,000
Q3 2020 Nov 06, 2020	SELL	$4.65 - $8.73 $166,005 - $311,661	-35,700 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$4.66 - $8.7 $166,362 - $310,590	35,700 New	35,700 $297,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $760M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.